Talaris Therapeutics Stock Technical Analysis
TALSDelisted Stock | USD 2.98 0.10 3.25% |
As of the 20th of December, Talaris Therapeutics has the Coefficient Of Variation of 846.74, risk adjusted performance of 0.1021, and Semi Deviation of 3.08. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Talaris Therapeutics, as well as the relationship between them. Please validate Talaris Therapeutics standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Talaris Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 2.98 per share. Please also confirm Talaris Therapeutics total risk alpha, which is currently at 0.4171 to double-check the company can sustain itself at a future point.
Talaris Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Talaris, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TalarisTalaris |
Talaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Talaris Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Talaris Therapeutics Trend Analysis
Use this graph to draw trend lines for Talaris Therapeutics. You can use it to identify possible trend reversals for Talaris Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Talaris Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Talaris Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Talaris Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Talaris Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1.27, which is the sum of squared deviations for the predicted Talaris Therapeutics price change compared to its average price change.About Talaris Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Talaris Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Talaris Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Talaris Therapeutics price pattern first instead of the macroeconomic environment surrounding Talaris Therapeutics. By analyzing Talaris Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Talaris Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Talaris Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Talaris Therapeutics December 20, 2024 Technical Indicators
Most technical analysis of Talaris help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Talaris from various momentum indicators to cycle indicators. When you analyze Talaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.1021 | |||
Market Risk Adjusted Performance | 0.4371 | |||
Mean Deviation | 3.42 | |||
Semi Deviation | 3.08 | |||
Downside Deviation | 3.47 | |||
Coefficient Of Variation | 846.74 | |||
Standard Deviation | 4.82 | |||
Variance | 23.24 | |||
Information Ratio | 0.1112 | |||
Jensen Alpha | 0.5286 | |||
Total Risk Alpha | 0.4171 | |||
Sortino Ratio | 0.1545 | |||
Treynor Ratio | 0.4271 | |||
Maximum Drawdown | 27.39 | |||
Value At Risk | (5.95) | |||
Potential Upside | 7.32 | |||
Downside Variance | 12.04 | |||
Semi Variance | 9.51 | |||
Expected Short fall | (4.19) | |||
Skewness | 1.76 | |||
Kurtosis | 6.08 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |